Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
NCT ID:
NCT05998512
Eligibility Criteria:
Inclusion criteria:
* Age \> 18 years
* Signed informed consent
* Diagnosis of fibrotic ILD of any type in the 12 months prior to inclusion.
* Radiologic fibrotic changes of at least 5% on chest CT scan
* Ability to comply with the study protocol (in the opinion of the investigator)
* Ability to understand the information given and to sign the informed consent form.
Exclusion Criteria
* Severe, advanced stage or life-limiting chronic diseases prior to the diagnosis of fibrotic ILD, or that represent a high risk of death in the short term (one year after inclusion), such as could be metastatic oncological metastatic diseases, advanced dementia, neurodegenerative diseases in a limiting phase.
* Pregnancy or breastfeeding
* Inability to complete required visits.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT05998512
Study Brief:
Protocol Section:
NCT05998512